Action of Punarnava Ghanavati on kidney.
Not Applicable
- Conditions
- Health Condition 1: E878- Other disorders of electrolyte andfluid balance, not elsewhere classified
- Registration Number
- CTRI/2020/07/026751
- Lead Sponsor
- Amit Gujrathi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Confirmed cases of CKD with raised microalbuminuria.
Patients of CKD having GFR less than 90ml/min; serum creatinine not more than 15mg%.
proteinuria not more than 300 mg/day.
CKD patient with HTN, DM, thyroid illness are to be included.
Exclusion Criteria
Patients excluded from inclusion criteria are excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Punarnava Ghanavati can be used as renal protective in the patients of CKDTimepoint: 12 weeks
- Secondary Outcome Measures
Name Time Method Punarnava Ghanavati can result in micro-albuminuria and overt-proteinuria.Timepoint: 3months